{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T19:55:47Z","timestamp":1785614147705,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study is aimed to compare the effect of oral misoprostol with vaginal misoprostol to induce labor as a systematic review and meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Electronic databases including PubMed [Medline], Scopus, Web of science, Embase, Ovid, Cochrane library, and ClinicalTrials.gov were searched using the relevant keywords. All RCTs comparing the effect of oral vs vaginal misoprostol on labor induction were considered. The Cochrane Risk of Bias checklist was used for assessing quality of included RCTs. All statistical analyses were completed using STATA (Version 16) and Revman (Version 5).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-three RCTs with 5162 patients (1560 in oral and 2602 in vaginal groups) were included in this meta-analysis. Labor induction length did differ significantly between the two routes of misoprostol administration [Standardized Mean Difference: 0.40\u00a0h, 95% confidence interval (CI) 0.34, 0.46;\u00a0I<jats:sup>2<\/jats:sup>: 66.35%; <jats:italic>P<\/jats:italic>\u2009=\u20090.04].\u00a0In addition, the risk of neonatal death, tachysystole, uterine hyperstimulation, preeclampsia, non-FHR and abortion was lower in the oral misoprostol group and the risk of hypertonus, PROM, oxytocin need and cesarean fever was higher in this group than the vaginal misoprostol group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Based on results of this meta-analysis, it can be inferred that currently, clinical specialists can decide to use this drug orally or vaginally on a case-by-case basis, depending on the condition of the pregnant mother and the baby.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01007-8","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T09:04:39Z","timestamp":1674810279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of the effect of oral and vaginal misoprostol on labor induction: updating a systematic review and meta-analysis of interventional studies"],"prefix":"10.1186","volume":"28","author":[{"given":"Maryam","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobin","family":"Azami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh Saghafian","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paniz","family":"Kazemzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"1007_CR1","volume-title":"Overview of obstetrics. Williams obstetrics","author":"FG Cunningham","year":"2010","unstructured":"Cunningham FG, et al. Overview of obstetrics. Williams obstetrics. 23rd ed. New York: McGraw-Hill; 2010.","edition":"23"},{"issue":"1","key":"1007_CR2","first-page":"90","volume":"21","author":"V Ghasemi","year":"2018","unstructured":"Ghasemi V, et al. Effective interventions for the induction of labor: a systematic review. Iran J Obstet, Gynecol Infertil. 2018;21(1):90\u2013104.","journal-title":"Iran J Obstet, Gynecol Infertil"},{"issue":"5","key":"1007_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/medicina57050478","volume":"57","author":"S Takakura","year":"2021","unstructured":"Takakura S, et al. The successful use of nitroglycerin for uterine hyperstimulation with fetal heart rate abnormality caused by a controlled-release dinoprostone vaginal delivery system (propess): a case report. Medicina. 2021;57(5):478.","journal-title":"Medicina"},{"issue":"3","key":"1007_CR4","first-page":"193","volume":"49","author":"P Tan","year":"2008","unstructured":"Tan P, et al. Predictors of newborn admission after labour induction at term: Bishop score, pre-induction ultrasonography and clinical risk factors. Singapore Med J. 2008;49(3):193.","journal-title":"Singapore Med J"},{"issue":"1","key":"1007_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijgo.2009.03.014","volume":"106","author":"MB Nagpal","year":"2009","unstructured":"Nagpal MB, Raghunandan C, Saili A. Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. Int J Gynecol Obstet. 2009;106(1):23\u20136.","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"1007_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ajog.2007.04.050","volume":"197","author":"AS Hatfield","year":"2007","unstructured":"Hatfield AS, Sanchez-Ramos L, Kaunitz AM. Sonographic cervical assessment to predict the success of labor induction: a systematic review with metaanalysis. Am J Obstet Gynecol. 2007;197(2):186\u201392.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1007_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0020-7292(02)00128-5","volume":"78","author":"B Chanrachakul","year":"2002","unstructured":"Chanrachakul B, Herabutya Y, Punyavachira P. Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. Int J Gynecol Obstet. 2002;78(2):139\u201345.","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"1007_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.AOG.0000172425.56840.57","volume":"106","author":"MG Lin","year":"2005","unstructured":"Lin MG, et al. Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis. Obstet Gynecol. 2005;106(3):593\u2013601.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1007_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"H-L Wu","year":"2017","unstructured":"Wu H-L, et al. Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Sci Rep. 2017;7(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"1","key":"1007_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1028-4559(10)60010-1","volume":"49","author":"C Kunt","year":"2010","unstructured":"Kunt C, et al. Randomized trial of vaginal prostaglandin E2 versus oxytocin for labor induction in term premature rupture of membranes. Taiwan J Obstet Gynecol. 2010;49(1):57\u201361.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"4","key":"1007_CR11","first-page":"242","volume":"20","author":"HZ Malik","year":"2010","unstructured":"Malik HZ, et al. Sublingual versus oral misoprostol for induction of labour in prelabour rupture of membranes at term. J Coll Physicians Surg Pak. 2010;20(4):242\u20135.","journal-title":"J Coll Physicians Surg Pak"},{"key":"1007_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejogrb.2019.10.023","volume":"243","author":"AM Abdelhakim","year":"2019","unstructured":"Abdelhakim AM, Gadallah A-H, Abbas AM. Efficacy and safety of oral vs vaginal misoprostol for cervical priming before hysteroscopy: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2019;243:111\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"1007_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/1471-0528.13456","volume":"123","author":"W Chen","year":"2016","unstructured":"Chen W, et al. A systematic review and network meta-analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour. BJOG: Intern J Obstet Gynaecol. 2016;123(3):346\u201354.","journal-title":"BJOG: Intern J Obstet Gynaecol"},{"issue":"4","key":"1007_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.fertnstert.2007.03.099","volume":"89","author":"C Batukan","year":"2008","unstructured":"Batukan C, et al. Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol. Fertil Steril. 2008;89(4):966\u201373.","journal-title":"Fertil Steril"},{"issue":"1","key":"1007_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000049405","volume":"53","author":"R Has","year":"2002","unstructured":"Has R, et al. Comparison of 25 and 50 \u03bcg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. Gynecol Obstet Invest. 2002;53(1):16\u201321.","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"1007_CR16","first-page":"346","volume":"24","author":"K Guha","year":"2015","unstructured":"Guha K, et al. Isosorbide mononitrate versus misoprostol for cervical ripening and induction of labour at term. Mymensingh Medical Journal: MMJ. 2015;24(2):346\u201351.","journal-title":"Mymensingh Medical Journal: MMJ"},{"issue":"3","key":"1007_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/01443615.2012.753422","volume":"33","author":"L Haghighi","year":"2013","unstructured":"Haghighi L, et al. Intravaginal isosorbide dinitrate or misoprostol for cervical ripening prior to induction of labour: a randomised controlled trial. J Obstet Gynaecol. 2013;33(3):272\u20136.","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"1007_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1\u20139.","journal-title":"Syst Rev"},{"issue":"2","key":"1007_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00404-011-1977-8","volume":"285","author":"D Ronel","year":"2012","unstructured":"Ronel D, et al. Trends, risk factors and pregnancy outcome in women with uterine rupture. Arch Gynecol Obstet. 2012;285(2):317\u201321.","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"1007_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1471-0528.1999.tb08399.x","volume":"106","author":"P Danielian","year":"1999","unstructured":"Danielian P, et al. Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel. BJOG: An International J Obstet Gynaecol. 1999;106(8):793\u20137.","journal-title":"BJOG: An International J Obstet Gynaecol"},{"issue":"3","key":"1007_CR21","first-page":"238","volume":"108","author":"A Shetty","year":"2001","unstructured":"Shetty A, Danielian P, Templeton A. A comparison of oral and vaginal misoprostol tablets in induction of labour at term. Br J Obstet Gynaecol. 2001;108(3):238\u201343.","journal-title":"Br J Obstet Gynaecol"},{"issue":"10","key":"1007_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/j.1471-0528.2007.01492.x","volume":"114","author":"AH Nassar","year":"2007","unstructured":"Nassar AH, et al. A randomised comparison of patient satisfaction with vaginal and sublingual misoprostol for induction of labour at term. BJOG An Internat J Obstet Gynaecol. 2007;114(10):1215\u201321.","journal-title":"BJOG An Internat J Obstet Gynaecol"},{"key":"1007_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16731","author":"K Cheung","year":"2022","unstructured":"Cheung K, et al. Clinical algorithms for management of fetal heart rate abnormalities during labour. BJOG: Internat J Obstet Gynaecol. 2022. https:\/\/doi.org\/10.1111\/1471-0528.16731.","journal-title":"BJOG: Internat J Obstet Gynaecol"},{"issue":"8","key":"1007_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1471-0528.1999.tb08400.x","volume":"106","author":"G Hofmeyr","year":"1999","unstructured":"Hofmeyr G, Gulmezoglu A, Alfirevic Z. Misoprostol for induction of labour: a systematic review. BJOG: Internat J Obstet Gynaecol. 1999;106(8):798\u2013803.","journal-title":"BJOG: Internat J Obstet Gynaecol"},{"key":"1007_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014484","author":"RS Kerr","year":"2021","unstructured":"Kerr RS, et al. Low-dose oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD014484.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1007_CR26","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.18203\/2320-1770.ijrcog20180958","volume":"7","author":"C Galidevara","year":"2018","unstructured":"Galidevara C, Chaturvedula L, Habeebullah S. Comparison of oral, vaginal and sublingual misoprostol for induction of labour in premature rupture of membranes after 34 weeks of gestation: a randomized controlled trial. Int J Reprod Contracept Obstet Gynecol. 2018;7(4):1341.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"6","key":"1007_CR27","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/0002-9378(95)91415-3","volume":"172","author":"DA Wing","year":"1995","unstructured":"Wing DA, et al. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1995;172(6):1804\u201310.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1007_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S0002-9378(97)70154-6","volume":"177","author":"DA Wing","year":"1997","unstructured":"Wing DA, Ortiz-Omphroy G, Paul RH. A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol. 1997;177(3):612\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1007_CR29","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/0002-9378(95)91416-1","volume":"172","author":"DA Wing","year":"1995","unstructured":"Wing DA, et al. Misoprostol: an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol. 1995;172(6):1811\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"1007_CR30","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.jgyn.2007.11.011","volume":"37","author":"E Verspyck","year":"2008","unstructured":"Verspyck E, Sentilhes L. Abnormal fetal heart rate patterns associated with different labour managements and intrauterine resuscitation techniques. J Gynecol Obstet Biol Reprod. 2008;37:S56-64.","journal-title":"J Gynecol Obstet Biol Reprod"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01007-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T09:09:28Z","timestamp":1674810568000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01007-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01007-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"16 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Iran University of Medical Sciences (IR.IUMS.REC.1400.955), Tehran, Iran.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}